Gufic Biosciences Ltd.
NSE: GUFICBIO | BSE: 509079
₹369.95
₹15.60
(4.40%)
As on 05-Jun-2026IST
Market cap
₹3,706 Cr
Revenue (TTM)
₹944 Cr
P/E Ratio
57.7
P/B Ratio
5.6
Div. Yield
0 %
Quality Score
4/10
Growth Score
8/10
Valuation Score
3/10
Momentum Score
4/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹64 Cr
-
ROE
12.3 %
-
ROCE
13.5 %
-
Industry P/E
35.23
-
EV/EBITDA
26.1
-
Debt to Equity
0.2
-
Book Value
₹66.3
-
EPS
₹6.4
-
Face value
1
-
Shares outstanding
100,282,506
10 Years Aggregate
CFO
₹321.06 Cr
EBITDA
₹829.52 Cr
Net Profit
₹453.01 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Gufic Biosciences
| 10.1 | 26.6 | 35.3 | -0.2 | 22.9 | 14.2 | 24.5 |
|
BSE Healthcare
| 8.0 | 3.6 | 8.8 | 9.9 | 24.9 | 13.6 | 12.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Gufic Biosciences
| -26.4 | 44.7 | 39.7 | -4.7 | 96.0 | 93.5 | -35.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Gufic Biosciences
|
370.0 | 3,705.9 | 944.0 | 64.2 | 12.8 | 9.9 | 57.7 | 5.6 |
| 2,976.5 | 37,200.8 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 35.2 | 8.2 | |
| 8,600.0 | 21,496.5 | 2,275.6 | 187.5 | 10.3 | 22.9 | 114.6 | 24.6 | |
| 2,033.1 | 15,441.4 | 2,187.2 | 649.7 | 31.5 | 19 | 24.1 | 4.3 | |
| 1,725.0 | 10,536.4 | 1,196.4 | 149.4 | -- | 27.5 | 56.9 | 14.1 | |
| 1,365.2 | 18,859.7 | 3,129.4 | 647.4 | 26.9 | 18.1 | 30.4 | 4.8 | |
| 2,169.3 | 34,833.2 | 4,147.8 | 709.5 | 22.3 | 19.1 | 49.1 | 8.4 | |
| 4,456.3 | 20,381.8 | 2,519.7 | 722.4 | 33.6 | 18.8 | 28.2 | 4.8 | |
| 6,200.0 | 10,245.6 | 1,408.0 | 326.9 | 30.8 | 57.1 | 31.3 | 19.5 | |
| 538.1 | 10,497.9 | 1,538.1 | 226.2 | 20.4 | 9 | 43.1 | 4.1 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Gufic Biosciences
Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, South America, and internationally. The company... manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. It manufactures lyophilized injections, which include antibiotic, antifungal, cardiac, infertility, antiviral, and proton-pump inhibitor segments. In addition, the company offers spark, criti care, criticare life, and ferticare pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products. It supplies its products to hospital chains and medical facilities. Gufic Biosciences Limited was founded in 1970 and is based in Mumbai, India. Read more
-
Incorporated
1984
-
Chairman
Jayesh P Choksi
-
Managing Director
Jayesh P Choksi
-
Headquarters
Mumbai, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for Gufic Biosciences
What is the current share price of Gufic Biosciences Ltd Today?
The share price of Gufic Biosciences Ltd is ₹369.95 (NSE) and ₹369.55 (BSE) as of 05-Jun-2026 IST. Gufic Biosciences Ltd has given a return of 22.93% in the last 3 years.
What is the current PB & PE ratio of Gufic Biosciences Ltd?
The P/E ratio of Gufic Biosciences Ltd is 57.71 times as on 05-Jun-2026, a 64 premium to its peers’ median range of 35.23 times.
The P/B ratio of Gufic Biosciences Ltd is 5.57 times as on 05-Jun-2026, a 21 premium to its peers’ median range of 4.62 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
48.44
|
5.61
|
|
2024
|
32.96
|
5.33
|
|
2023
|
22.70
|
5.20
|
|
2022
|
25.18
|
8.97
|
|
2021
|
25.05
|
6.39
|
What is the 52 Week High and Low of Gufic Biosciences Ltd?
The 52-week high and low of Gufic Biosciences Ltd are Rs 407.85 and Rs 268.00 as of 06-Jun-2026.
What is the market cap of Gufic Biosciences Ltd?
Gufic Biosciences Ltd has a market capitalisation of ₹ 3,706 Cr as on 05-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Gufic Biosciences Ltd?
Before investing in Gufic Biosciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.